Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STM vs MRNA✓SelectedUSD · MRNASTM vs MRNA performance historyLatest closeAs of+1.56%11/18
Stock and ETF performance explorer

STM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+260.7%
MRNA return
+794.5%
Excess return
-533.8%
Maximum drawdown
-66.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.6%-4.8%+6.4%+1.9%
7D-2.9%-20.9%+18.0%-1.2%
30D-1.5%-13.3%+11.7%-0.6%
3M-13.9%+212.6%-226.5%-27.3%
6M-26.1%+309.0%-335.2%-40.5%
YTD+74.1%+567.3%-493.2%+29.1%
1Y+102.9%+689.7%-586.8%+46.3%
3Y+1.2%+157.4%-156.2%-18.4%
5Y-10.1%-21.7%+11.6%-21.5%
All+260.7%+794.5%-533.8%+188.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling